Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00734695

Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment.

The Effect of Subconjunctival Vitamin c on Recovery Rate and End Result From Eye Burn.

Status
Withdrawn
Phase
Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
The Baruch Padeh Medical Center, Poriya · Other Government
Sex
All
Age
90 Years
Healthy volunteers
Not accepted

Summary

Eye burns may cause a severe permanent damage. One kind of treatment is the use of vitamin C (Ascorbic acid). This study will compare between subconjunctival topical and/or systemic route of administration and topical and/or systemic administration.

Detailed description

In order to prevent permanent and severe damage to the eye after eye burn early treatment is mandatory. It is well known and published that the use of Vitamin c may contribute to the healing process of such burns, including burns from chemicals or heat. We believe that the route pf administration of the medicine is as important as the kind of medicine and that subconjunctival injection will have better effect and will influence in a favorable manner on the the end result as well as on the time of the healing. In order to be able to compare between cases we made a new definition of the severity of the burn according to the extension of the damage on the cornea, conjunctiva and limbus, and according to the severity and depth of the ischemia. In 3 medical centers 3 protocols of treatment and followup will be compared while only in Baruch Pade Medical Center the main route of administration will be subconjunctival on top of the topical treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTvitamin cSubconjunctival daily or bid
DIETARY_SUPPLEMENTvitamin ctopical and systemic
DIETARY_SUPPLEMENTvitamin ctopical systemic

Timeline

Start date
2009-07-01
Primary completion
2009-11-01
Completion
2010-02-01
First posted
2008-08-14
Last updated
2010-03-02

Locations

2 sites across 1 country: Israel

Source: ClinicalTrials.gov record NCT00734695. Inclusion in this directory is not an endorsement.